Lopez Gonzalez Santana Corporation dba Domel and dba Dermixx
Compiled by the Supplement Safety Data Team | Sourced from Official FDA Records on July 16, 2018
Executive Summary
The FDA issued a warning letter to Lopez Gonzalez Santana Corporation dba Domel and dba Dermixx on July 16, 2018 citing regulatory violations. The letter was issued by San Juan District Office.
Detailed Analysis
False Claims and Regulatory Violations
Your Calci-Max product label claims “L-methylfolate” on the primary display panel, but the Supplement Facts label declares “methylfolate.”
Potential Health Risks
Consumers should be aware of potential risks associated with products from Lopez Gonzalez Santana Corporation dba Domel and dba Dermixx.
Regulatory Context
Be held using the same container-closure system in which the packaged and labeled dietary supplements were distributed [21 CFR 111.83(b)(1)].
Be identified with the appropriate batch, lot, or control number [21 CFR 111.83(b)(2)].
Be retained for one year past the shelf life date (if shelf life dating is used), or for two years from the date of distribution of the last batch of dietary supplement associated with the reserve sample [21 CFR 111.83(b)(3)].
Key Entities Identified
Frequently Asked Questions
- What did the FDA find wrong with Lopez Gonzalez Santana Corporation dba Domel and dba Dermixx?
- The FDA issued a warning letter citing regulatory violations related to their products or manufacturing practices.
- Are Lopez Gonzalez Santana Corporation dba Domel and dba Dermixx products safe to use?
- Based on the FDA's findings, consumers should exercise caution. The company was found to have regulatory issues that may affect product safety.
- What should I do if I've used Lopez Gonzalez Santana Corporation dba Domel and dba Dermixx products?
- If you have used products from Lopez Gonzalez Santana Corporation dba Domel and dba Dermixx and experience any adverse effects, contact your healthcare provider immediately. You can also report adverse events to the FDA's MedWatch program.
Source Document
This report is based on an official FDA warning letter. The original document is a public record.
View Original FDA Warning Letter